Carolyn Bertozzi and Degrading Drugs for Problematic Proteins

Carolyn Bertozzi and Degrading Drugs for Prob...

Up next

Moderna CEO Stéphane Bancel on the Next Era of mRNA

a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck’s individualized treatment for melanoma, after more than a decade of work on personalized cancer vaccines. ...  Show more

Clinical AI Comes of Age | Suchi Saria on the Future of Healthcare

Julie Yoo sits down with Dr. Suchi Saria, founder and CEO of Bayesian Health, to discuss the current state of clinical AI and what it takes to deploy AI systems in real-world healthcare settings. While much of the recent attention around AI has focused on copilots, chatbots, and ...  Show more

Recommended Episodes

Degrading Drugs for Problem Proteins: Journal Club now on Bio Eats World (ep 2)
The a16z Show

Welcome to the second episode of Bio Eats World, a brand new podcast all about how biology

  Show more

Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology
Science and Technology

"Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology" - In this episode, we dive deep into the revolutionary world of biotechnology and its transformative impact on pharmaceuticals. Discover how cutting-edge innovations are reshaping drug development, accelerating vac ...  Show more

The Biology of Aging: Introducing Bio Eats World (ep 1)
The a16z Show

Welcome to the first episode of Bio Eats World, a brand new podcast all about how biology is technology. Bio is breaking out o ...

  Show more

Why building new proteins from scratch is our new superpower | David Baker
TED Talks Daily

The rapidly evolving field of protein design is revealing solutions to some of the world’s greatest problems, whether it's blocking a virus, breaking down a pollutant or creating brand-new materials. In conversation with TED’s Whitney Pennington Rodgers, biochemist David Baker ex ...  Show more